Skip to main content
. 2022 Mar 23;12(3):e12129. doi: 10.1002/clt2.12129

TABLE 1.

Demographic and disease characteristics at inclusion of patients in the SAF population

Parameter at inclusion Statistics AR alone AA Total
Total patients N 984 499 1483
Age (years) N 984 499 1483
Mean (SD) 34.2 (11.6) 34.3 (11.2) 34.2 (11.5)
Gender N 984 499 1483
Female n (%) 581 (59.0) 286 (57.3) 867 (58.5)
Smoking habits N 984 499 1483
Non‐smoker n (%) 789 (80.2) 396 (79.4) 1185 (79.9)
Allergy history
At least one respiratory allergy or sensitization (other than HDM) n (%) 573 (58.2) a 370 (74.1) a 943 (63.6)
Disease characteristics
Evaluation of rhinitis according to ARIA 2010 N 980 498 1478
Intermittent mild rhinitis n (%) 41 (4.2) 41 (8.2) 82 (5.5)
Intermittent moderate–severe rhinitis n (%) 44 (4.5) 44 (8.8) 88 (6.0)
Persistent mild rhinitis n (%) 44 (4.5) 39 (7.8) 83 (5.6)
Persistent moderate–severe rhinitis n (%) 851 (86.8) 374 (75.1) 1225 (82.9)
Severity of asthma according to GINA report 2017, n (%) N 498 498
GINA—Step 1 n (%) NA 148 (33.7) 148 (33.7)
GINA—Step 2 n (%) NA 68 (13.7) 68 (13.7)
GINA—Step 3 n (%) NA 211 (42.4) 211 (42.4)
GINA—Step 4 n (%) NA 49 (9.8) 49 (9.8)
GINA—Step 5 n (%) NA 2 (0.4) 2 (0.4)
Level of asthma control according to GINA report 2017, n (%) 494 494
Well controlled n (%) NA 266 (53.8) 266 (53.8)
Partly controlled n (%) NA 138 (27.9) 138 (27.9)
Uncontrolled n (%) NA 90 (18.2) 90 (18.2)

Abbreviations: BMI, body mass index; SD, standard deviation.

a

Chi2 test: p < 0.0001.